These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25541746)

  • 1. Synthesis and In-Vitro Cytotoxicity of (E)-N,2,3-Triarylacrylamide Derivatives as Analogs of Combretastatin A-4.
    Jiang KM; Dai XL; Li K; Wu D; Zhang JH; Jin Y; Lin J
    Med Chem; 2015; 11(5):453-61. PubMed ID: 25541746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combretastatin-chalcone hybrids: synthesis and cytotoxicity.
    Nam NH; Byung-Zun A
    Med Chem; 2007 Jul; 3(4):373-7. PubMed ID: 17627575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
    Sharma S; Gupta MK; Saxena AK; Bedi PM
    Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents.
    Liu YQ; Li XJ; Zhao CY; Nan X; Tian J; Morris-Natschke SL; Zhang ZJ; Yang XM; Yang L; Li LH; Zhou XW; Lee KH
    Bioorg Med Chem; 2013 Mar; 21(5):1248-56. PubMed ID: 23369687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Anticancer Screening and Molecular Docking Studies of New Heterocycles with Trimethoxyphenyl Scaffold as Combretastatin Analogues.
    Ali KA; Abdel Hafez NA; Elsayed MA; El-Shahawi MM; El-Hallouty SM; Amr AEE
    Mini Rev Med Chem; 2018; 18(8):717-727. PubMed ID: 28443521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of isoerianin analogues as promising anticancer agents.
    Messaoudi S; Hamze A; Provot O; Tréguier B; Rodrigo De Losada J; Bignon J; Liu JM; Wdzieczak-Bakala J; Thoret S; Dubois J; Brion JD; Alami M
    ChemMedChem; 2011 Mar; 6(3):488-97. PubMed ID: 21360820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 3-(trimethoxyphenyl)-2(3H)-thiazole thiones as combretastatin analogs.
    Banimustafa M; Kheirollahi A; Safavi M; Kabudanian Ardestani S; Aryapour H; Foroumadi A; Emami S
    Eur J Med Chem; 2013; 70():692-702. PubMed ID: 24219991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of pyrimidine bridged combretastatin derivatives as potential anticancer agents and mechanistic studies.
    Kumar B; Sharma P; Gupta VP; Khullar M; Singh S; Dogra N; Kumar V
    Bioorg Chem; 2018 Aug; 78():130-140. PubMed ID: 29554587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy.
    Sriram M; Hall JJ; Grohmann NC; Strecker TE; Wootton T; Franken A; Trawick ML; Pinney KG
    Bioorg Med Chem; 2008 Sep; 16(17):8161-71. PubMed ID: 18722127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
    Devkota L; Lin CM; Strecker TE; Wang Y; Tidmore JK; Chen Z; Guddneppanavar R; Jelinek CJ; Lopez R; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2016 Mar; 24(5):938-956. PubMed ID: 26852340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advancement in discovery and development of natural product combretastatin-inspired anticancer agents.
    Patil PO; Patil AG; Rane RA; Patil PC; Deshmukh PK; Bari SB; Patil DA; Naphade SS
    Anticancer Agents Med Chem; 2015; 15(8):955-69. PubMed ID: 26007283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and cytotoxicity of novel 3'-N-alkoxycarbonyl docetaxel analogs.
    Chang J; Hao XD; Hao YP; Lu HF; Yu JM; Sun X
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6834-7. PubMed ID: 24269481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of fluorinated combretastatin analogues.
    Alloatti D; Giannini G; Cabri W; Lustrati I; Marzi M; Ciacci A; Gallo G; Tinti MO; Marcellini M; Riccioni T; Guglielmi MB; Carminati P; Pisano C
    J Med Chem; 2008 May; 51(9):2708-21. PubMed ID: 18396857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combretastatin A-4 analogues with benzoxazolone scaffold: Synthesis, structure and biological activity.
    Gerova MS; Stateva SR; Radonova EM; Kalenderska RB; Rusew RI; Nikolova RP; Chanev CD; Shivachev BL; Apostolova MD; Petrov OI
    Eur J Med Chem; 2016 Sep; 120():121-33. PubMed ID: 27187864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxicity of epoxide and pyrazole analogs of the combretastatins.
    LeBlanc R; Dickson J; Brown T; Stewart M; Pati HN; VanDerveer D; Arman H; Harris J; Pennington W; Holt HL; Lee M
    Bioorg Med Chem; 2005 Nov; 13(21):6025-34. PubMed ID: 16055334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues.
    Li YH; Zhang B; Yang HK; Li Q; Diao PC; You WW; Zhao PL
    Eur J Med Chem; 2017 Jan; 125():1098-1106. PubMed ID: 27810596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines.
    Demchuk DV; Samet AV; Chernysheva NB; Ushkarov VI; Stashina GA; Konyushkin LD; Raihstat MM; Firgang SI; Philchenkov AA; Zavelevich MP; Kuiava LM; Chekhun VF; Blokhin DY; Kiselyov AS; Semenova MN; Semenov VV
    Bioorg Med Chem; 2014 Jan; 22(2):738-55. PubMed ID: 24387982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of nitrogen-containing macrocyclic bisbibenzyl derivatives as potent anticancer agents by targeting the lysosome.
    Sun B; Liu J; Gao Y; Zheng HB; Li L; Hu QW; Yuan HQ; Lou HX
    Eur J Med Chem; 2017 Aug; 136():603-618. PubMed ID: 28570977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and cytotoxicity studies of novel 2-Hydrazonylpyrido[2,3-b]pyrazin-3(4H)-ones.
    Zhang G; Liu Y; Wang S; Zhou C; Huang Q; Gong P
    Arch Pharm (Weinheim); 2012 Jan; 345(1):49-56. PubMed ID: 21953529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship study of arylsulfonylimidazolidinones as anticancer agents.
    Sharma VK; Lee KC; Venkateswararao E; Joo C; Kim MS; Sharma N; Jung SH
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6829-32. PubMed ID: 21983438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.